Age is a key factor. Despite Wegovy receiving FDA approval for children ages 12 and up, only 0.2% of Americans under 18 with ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

Despite policies that have been created with the goal of limiting kids’ sugar intake via sweetened drinks, a new study conducted by researchers from the UConn Rudd Center for Food Policy and Obesity ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

But now researchers in Lebanon, who tracked more than 200 obese adults in their 70s ... Deficiency leads to rickets in ...

Adopting a healthy diet and engaging in regular physical activity are essential for preventing weight gain. Small steps can ...

Investigating ultra-processed food and screen time, this study examines their effects on weight and well-being in adolescents ...

Age is a key factor. Despite Wegovy receiving FDA approval for children ages 12 and up, only 0.2% of Americans under 18 with ...

GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...

People with both type 2 diabetes and chronic kidney disease face a heart health double-whammy, a new study says.

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...